Highly potent ligands of the ghrelin receptor to influence food intake

Summary:

A German University has developed synthesized short peptides that show high inverse agonist potency towards the ghrelin receptor, which is useful in the treatment of feeding-related disorders, such as obesity. The endogenous ligand ghrelin is the only known orexigenic gastrointestinal peptide and plays a central role in the regulation of appetite and energy homeostasis. The university is looking for partners from industry for further R&D and license agreements.

Reference: TODE20190305002

Country: Germany

Submitted: 16. 8. 2019

View Partnering Opportunity

Keywords

Technology: Protein Engineering; Genetic Engineering; Microbiology

Market: Population genetics; Therapeutic services

NACE: Research and experimental development on biotechnology

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.